On Friday, UBS made a notable adjustment to its stance on Mobileye N.V (NASDAQ:MBLY) stock, a company specializing in autonomous driving technologies.
The firm downgraded the stock from Buy to Neutral and concurrently lowered its price target to $14.00, a decrease from the previous figure of $20.00. The change in outlook is attributed to several challenges that the company faces, including its market performance and technological concerns.
The analyst from UBS acknowledged that the decision comes after Mobileye's stock has significantly underperformed and that the market is now well aware of the company's difficulties. These include a less favorable product mix in China, delays in the rollout of their SuperVision technology, and broader technological hurdles that have impacted the company's growth prospects.
UBS also anticipates that Mobileye will have to go through a period of transition, especially in the year 2025, before it can return to growth. This adjustment period is expected to necessitate substantial revisions to the current consensus forecasts for the company's revenue. UBS's own revenue estimates for the years 2025 to 2027 are approximately 28% lower than the market consensus.
Despite acknowledging Mobileye's potential long-term value as a partner for non-Chinese automakers, UBS suggests that the stock might not see significant movement until the necessary adjustments to forecasts are made. Additionally, the firm pointed out that Intel's ownership of Mobileye introduces an extra element of uncertainty for investors.
In conclusion, UBS has decided to adopt a more cautious approach with Mobileye, recommending to remain on the sidelines until the forecast "reset" is fully realized and the uncertainties surrounding the company's outlook are addressed.
In other recent news, Qualcomm (NASDAQ:QCOM) Inc. has been rumored to be considering a takeover of Intel Corp (NASDAQ:INTC)., a development Deutsche Bank views as improbable due to regulatory challenges and the need for significant restructuring. The bank also notes Intel's commitment to its existing strategy as a more likely scenario for the company's future.
In parallel, Mobileye, a subsidiary of Intel, reported a strong Q2 growth with an 84% increase in revenue, reaching $439 million, primarily driven by increased EyeQ and SuperVision volumes.
Mobileye has been the subject of several analyst reviews, with Canaccord Genuity maintaining a Buy rating and a steady price target of $27.00, while Deutsche Bank resumed coverage with a Hold rating and a price target of $15.00. Wolfe Research assumed coverage with a Peerperform rating, indicating a neutral stance on Mobileye's stock.
RBC Capital reduced its price target from $34 to $24 but maintained an Outperform rating, and Citi revised its price target from $53.00 to $32.00, while keeping a Buy rating.
These recent developments come amidst speculation around Intel's plans for its Mobileye stake and the company's strategic moves in its EyeQ6 platform and Brain6 technology. Despite facing challenges in the Chinese market, Mobileye remains optimistic about its long-term prospects in the region, particularly through collaborations with Zeekr on next-generation vehicles.
InvestingPro Insights
Recent data from InvestingPro adds context to UBS's downgrade of Mobileye N.V (NASDAQ:MBLY). The company's market capitalization stands at $10.05 billion, reflecting the significant stock price decline mentioned in the article. This decline is further evidenced by InvestingPro data showing a 54.83% price drop over the last three months and a 69.86% decrease over the past year.
InvestingPro Tips highlight that Mobileye "holds more cash than debt on its balance sheet" and "liquid assets exceed short term obligations," which could provide some financial stability during the transition period UBS anticipates. However, aligning with UBS's concerns, another InvestingPro Tip notes that "analysts anticipate sales decline in the current year," supporting the need for forecast revisions.
The company's current challenges are reflected in its financial metrics, with a negative operating income of $251 million in the last twelve months as of Q2 2024. This aligns with the InvestingPro Tip stating that Mobileye is "not profitable over the last twelve months."
For investors seeking a more comprehensive analysis, InvestingPro offers 13 additional tips for Mobileye, providing a deeper understanding of the company's financial health and market position during this critical period.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.